1. Immunopathogenesis of Immune Checkpoint Inhibitor-Related Adverse Events: Roles of the Intestinal Microbiome and Th17 Cells
   Ronald Anderson et al, 2019, Frontiers in Immunology CrossRef
2. METTL3/14 and IL‐17 signaling contribute to CEBPA‐DT enhanced oral cancer cisplatin resistance
   Xue Qiao et al, 2023, Oral Diseases CrossRef
3. TH9, TH17, and TH22 Cell Subsets and Their Main Cytokine Products in the Pathogenesis of Colorectal Cancer
   Guanglin Cui, 2019, Frontiers in Oncology CrossRef
4. CD47 is a negative regulator of intestinal epithelial cell self-renewal following DSS-induced experimental colitis
   Yueqin He et al, 2020, Scientific Reports CrossRef
5. IL-17A Increases Doxorubicin Efficacy in Triple Negative Breast Cancer
   Nicholas R. Hum et al, 2022, Frontiers in Oncology CrossRef
6. Cytokine-mediated crosstalk between cancer stem cells and their inflammatory niche from the colorectal precancerous adenoma stage to the cancerous stage: Mechanisms and clinical implications
   Guanglin Cui et al, 2022, Frontiers in Immunology CrossRef
7. Circulating IL-17 reduces the risk of cisplatin-induced hearing loss in children: a bidirectional two-sample Mendelian randomization study
   Ying Xu et al, 2023, Scientific Reports CrossRef
8. Role of CC Chemokines Subfamily in the Platinum Drugs Resistance Promotion in Cancer
   Maria E. Reyes et al, 2020, Frontiers in Immunology CrossRef
9. High-Grade Inflammation Attenuates Chemosensitivity and Confers to Poor Survival of Surgical Stage III CRC Patients
   Hou-Qun Ying et al, 2021, Frontiers in Oncology CrossRef
10. Act1 drives chemoresistance via regulation of antioxidant RNA metabolism and redox homeostasis
    Lingzi Hong et al, 2024, Journal of Experimental Medicine CrossRef